Associate Professor of Pharmacology and Cancer Biology
Our laboratory uses genomic and pharmacological approaches to understand how tumor dependencies are shaped by cell intrinsic factors, environmental factors, and drug treatments during the dynamic process of tumor evolution. To learn more, please visit our laboratory website: https://woodlabduke.com/.
Appointments and Affiliations
- Associate Professor of Pharmacology and Cancer Biology
- Associate Professor of Cell Biology
- Core Faculty in Innovation & Entrepreneurship
- Member of the Duke Cancer Institute
Contact Information
- Email Address: kris.wood@duke.edu
- Websites:
Education
- Ph.D. Massachusetts Institute of Technology, 2007
Courses Taught
- CMB 710B: Cell & Molecular Biology Module II
- CMB 710E: Cell & Molecular Biology Module V
- MOLCAN 818: Molecular Mechanisms of Oncogenesis
- PHARM 393: Research Independent Study
- PHARM 394: Research Independent Study
- PHARM 493: Research Independent Study
- PHARM 494: Research Independent Study
- PHARM 495: Research Independent Study
- PHARM 818: Molecular Mechanisms of Oncogenesis
- UPGEN 778A: University Program in Genetics and Genomics Biological Solutions Module I
In the News
- Locking Leukemia's Cellular Escape Hatch (Jun 7, 2022 | Pratt)
- Cancer Repair Mechanism Could Be Potential Drug Target (Mar 31, 2022 | Duke Hea…
- Cancer Therapy Using Genetic Targeting and Gel Delivery Shows Promise (Sep 16, …
- From Innovation to Impact (Oct 3, 2018 | Duke Med Alumni News)
- Faculty Startup Sold to Belgian Pharma for $30 Million (Apr 9, 2018)
- Why Do Perfectly Good Cancer Treatments Suddenly Stop Working? (Oct 25, 2017 | …
- The Challenges of Combating Cancer Drug Resistance (Nov 18, 2015 | Duke Researc…
- Researchers Map Paths to Cancer Drug Resistance (Jan 4, 2015 | Duke Today)
Representative Publications
- Wood, Kris C. “Hyperactivation of oncogenic driver pathways as a precision therapeutic strategy.” Nat Genet, September 25, 2023. https://doi.org/10.1038/s41588-023-01493-w.
- Ang, Hazel X., Natalia Sutiman, Xinyue L. Deng, Annie Liu, Christian G. Cerda-Smith, Haley M. Hutchinson, Holly Kim, et al. “Cooperative regulation of coupled oncoprotein synthesis and stability in triple-negative breast cancer by EGFR and CDK12/13.” Proc Natl Acad Sci U S A 120, no. 38 (September 19, 2023): e2221448120. https://doi.org/10.1073/pnas.2221448120.
- Killarney, Shane T., Stephen W. G. Tait, Douglas R. Green, and Kris C. Wood. “Sublethal engagement of apoptotic pathways in residual cancer.” Trends Cell Biol, August 10, 2023. https://doi.org/10.1016/j.tcb.2023.07.005.
- Stanland, Lyla J., Hazel X. Ang, Jacob P. Hoj, Yunqiang Chu, Patrick Tan, Kris C. Wood, and Micah A. Luftig. “Supplementary Figure Legends 1-7 from CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer,” August 9, 2023. https://doi.org/10.1158/1541-7786.23912456.
- Stanland, Lyla J., Hazel X. Ang, Jacob P. Hoj, Yunqiang Chu, Patrick Tan, Kris C. Wood, and Micah A. Luftig. “Figure S2 from CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer,” August 9, 2023. https://doi.org/10.1158/1541-7786.23912474.v1.